• Ouabain (SKU B2270): Assay Precision for Na⁺/K⁺-ATPase Resea

  2026-06-29

  This article provides a scenario-driven, evidence-based guide to using Ouabain (SKU B2270) as a selective Na⁺/K⁺-ATPase inhibitor in cell viability, cytotoxicity, and cardiovascular assays. We address real laboratory challenges with validated protocols, quantitative data, and direct links to Ouabain’s product page for workflow optimization.

• G007-LK Tankyrase 1/2 Inhibitor: Precision for Wnt Pathway R

  2026-06-29

  G007-LK delivers unmatched selectivity and potency as a tankyrase 1/2 inhibitor, making it indispensable for dissecting Wnt/β-catenin and Hippo pathway mechanisms in APC-mutant colorectal and liver cancer models. Its robust performance and workflow versatility empower researchers to achieve reproducible results in challenging cell-based and in vivo systems.

• BFH772 (VEGFR2 Inhibitor): Technical Protocol and Workflow G

  2026-06-28

  BFH772 is a potent and selective VEGFR2 inhibitor designed for precise modulation of VEGFR2-mediated angiogenesis in tumor model research. It is optimal for workflows requiring high kinase selectivity and compatibility with organic solvents, but is unsuitable for protocols demanding water solubility or broad-spectrum kinase inhibition.

• Dual Recombinase Tracing Disproves Postnatal Neo-oogenesis i

  2026-06-27

  A recent study by Xie, Zhou, and Zheng employs dual recombinase-mediated genetic tracing to rigorously test whether new oocytes are generated in mice after birth. Their findings demonstrate that postnatal neo-oogenesis does not occur, even following targeted ovarian injury, providing critical clarity for germ cell lineage research and experimental model design.

• Acifran: Selective HM74A/GPR109A Agonist for Lipid Metabolis

  2026-06-26

  Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) is a highly selective agonist for hydroxycarboxylic acid receptors involved in lipid metabolism regulation. Recent structural biology advances confirm its precise binding and functional specificity, establishing Acifran as a benchmark hypolipidemic agent for research applications.

• Busulfan (SKU A8386): Reliable Induction of Senescence & Ger

  2026-06-26

  This article offers a scenario-driven, evidence-based guide to using Busulfan (SKU A8386) for cell viability, senescence, and germ cell depletion assays. Drawing from validated protocols, mechanistic insights, and recent genetic tracing studies, it addresses common laboratory challenges with reproducible strategies for maximizing experimental reliability. APExBIO's Busulfan is highlighted for its robust performance, solubility, and data-backed utility in advanced biological models.

• Streptavidin-Cy3: Workflow Solutions for Biotin Detection As

  2026-06-25

  Streptavidin-Cy3 from APExBIO delivers bright, reliable fluorescence for biotin labeling workflows in IHC, IF, and flow cytometry. Discover proven strategies, optimization tips, and protocol parameters that maximize sensitivity and reproducibility in cancer metastasis and molecular detection studies.

• ATRX Deficiency Sensitizes Glioma to Selective PDGFR Inhibit

  2026-06-25

  The reference study identifies ATRX-deficient high-grade glioma cells as particularly sensitive to receptor tyrosine kinase and PDGFR inhibitors, highlighting ATRX mutation status as a crucial biomarker for therapeutic response. These findings suggest that integrating ATRX profiling could improve targeted therapy strategies and interpretation of clinical trial outcomes.

• Quizartinib (AC220): Advanced FLT3 Inhibition for AML Resear

  2026-06-24

  Quizartinib (AC220) delivers nanomolar-selective FLT3 inhibition, redefining acute myeloid leukemia (AML) research workflows from cell-based assays to in vivo models. This guide details actionable protocols, troubleshooting strategies, and data-driven insights to maximize the impact of Quizartinib in both mechanistic and translational settings.

• Sisomicin: Mechanistic Insights and Translational Impact

  2026-06-23

  This thought-leadership article explores Sisomicin’s mechanistic foundation, benchmarking its efficacy in translational infection models, and offers actionable protocol guidance for researchers. Integrating recent comparative evidence and reference studies, the piece positions Sisomicin (APExBIO SKU BA1199) as an essential tool in Gram-negative and Gram-positive bacterial infection research, while also addressing resistance dynamics and best practices for in vitro and in vivo assay design.

• Acridine Orange hydrochloride: Technical Use and QC Guidance

  2026-06-23

  Acridine Orange hydrochloride enables reliable, differential fluorescent staining of DNA and RNA for cell cycle analysis, apoptosis detection, and flow cytofluorometric applications. It is not suitable for protocols requiring solution stability beyond short-term use or for applications outside nucleic acid staining workflows. Users should follow product-specific concentration, solubility, and storage guidelines to maximize assay performance.

• 5-Methyl-CTP: Optimizing mRNA Synthesis for Enhanced Stabili

  2026-06-22

  5-Methyl-CTP is transforming mRNA synthesis workflows by mimicking natural methylation, leading to improved stability and translation efficiency. Explore protocol enhancements, troubleshooting solutions, and actionable insights for mRNA vaccine and therapeutic development using this advanced nucleotide.

• Etomoxir in Immunometabolic Assays: Insights Beyond Protocol

  2026-06-22

  Discover how Etomoxir, a potent CPT-1 inhibitor, enables advanced immunometabolic research by revealing nuanced immune-metabolism interactions. This article provides a deeper analysis of assay design, referencing innovative whole-blood protocols and highlighting Etomoxir’s unique impact on functional immune studies.

• Phenothiazines Boost Macrophage Antibacterial Function via R

  2026-06-21

  Qiu et al. (2025) reveal that phenothiazines, including compounds from the antipsychotic drug class, significantly enhance macrophage antibacterial activity by inducing both reactive oxygen species (ROS) and autophagy. This mechanistic insight highlights the potential of host-directed therapies to address antibiotic-resistant intracellular infections.

• Hypoxia-Induced Cognitive Impairment: Choroid Plexus and Mac

  2026-06-20

  This study elucidates how hypoxic exposure at high altitude impairs cognitive function in mice by disrupting the choroid plexus barrier through pathological M1 macrophage polarization and aberrant AMPK signaling. The findings clarify a mechanistic cascade linking hypoxic stress, neuroimmune modulation, and CNS dysfunction, revealing new intervention targets for hypoxia-induced cognitive disorders.

451 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page